首页 > 最新文献

Journal of Clinical Neuroscience最新文献

英文 中文
Spontaneous perforation of septum pellucidum – A rare marker of chronic hydrocephalus 透明隔自发性穿孔--慢性脑积水的罕见标志物
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-28 DOI: 10.1016/j.jocn.2024.110885
Ram Kishan Nekkanti, Gowtham Matham, Krishnakumar Kesavapisharady, H.V. Easwer
{"title":"Spontaneous perforation of septum pellucidum – A rare marker of chronic hydrocephalus","authors":"Ram Kishan Nekkanti, Gowtham Matham, Krishnakumar Kesavapisharady, H.V. Easwer","doi":"10.1016/j.jocn.2024.110885","DOIUrl":"10.1016/j.jocn.2024.110885","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110885"},"PeriodicalIF":1.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudocapsular dissection in a large plurihormonal Pit-1 positive PitNET 大面积多激素 Pit-1 阳性 PitNET 的假包膜剥离。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-28 DOI: 10.1016/j.jocn.2024.110887
Nicholas G. Candy , Stephen Santoreneos , Peter-John Wormald
{"title":"Pseudocapsular dissection in a large plurihormonal Pit-1 positive PitNET","authors":"Nicholas G. Candy , Stephen Santoreneos , Peter-John Wormald","doi":"10.1016/j.jocn.2024.110887","DOIUrl":"10.1016/j.jocn.2024.110887","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110887"},"PeriodicalIF":1.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety and efficacy of NeVa mechanical thrombectomy device in acute ischemic stroke: A systematic review and meta-analysis NeVa 机械血栓切除装置在急性缺血性脑卒中中的安全性和有效性:系统综述与荟萃分析。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-28 DOI: 10.1016/j.jocn.2024.110892
Mohammad Amin Habibi , Mohammad Sina Mirjnani , Saeed Kargar-Soleimanabad , Mohammad Taha Akbari Javar , Maryam Diyanati , Muhammad Hussain Ahmadvand , Inka K. Berglar , Adam A. Dmytriw

Background

Recent favorable cohort studies on endovascular therapy for ischemic stroke have predominantly utilized NeVa thrombectomy (NeVaTM) stent retrievers. We carried out a systematic review and meta-analysis to investigate the efficacy and safety of this second-generation stent retriever in acute ischemic stroke patients.

Method

We conducted the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The electronic databases of PubMed, Embase, and Scopus were searched until 26 November 2023 and was updated on August 1, 2024.

Results

This meta-analysis systematically investigated 11 studies with a total of 805 patients suffering from ischemic stroke. The mean age of participants across the studies ranged from 65 to 77 years with a male preponderance of 50.16 %. While ten studies reported on the etiology of strokes, some studies reported the risk factors such as hypertension, dyslipidemia, diabetes, history of coronary artery disease, and previous stroke. The results of our study indicate that the all-hemorrhagic complications rate was 0.32 (95 %CI: 0.18–0.45), while the complete arterial recanalization rate was 0.76 [95 %CI: 0.49–1.04]. The overall recanalization rate was found to be 0.97 [95 %CI: 0.94–1.00]. Moreover, the postoperative hemorrhage rate was 0.28 [95 %CI: 0.14–0.41], while the repeated re-thrombosis rate was 0.01 [95 %CI: −0.01–0.03]. Lastly, the vasospasm rate was calculated to be 0.09 [95 %CI: −0.03–0.21].

Conclusion

NeVa™ is a safe option capable of achieving a high rate of recanalization and functional independence.
Abbreviations: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO, International Prospective Register of Systematic Reviews; NeVa™, NeVa Thrombectomy; ICH, Intracranial Hemorrhage; mTICI, modified Thrombolysis in Cerebral Infarction; mRS, modified Rankin Scale; ACA, Anterior Cerebral Artery; MCA, Middle Cerebral Artery; PCA, Posterior Cerebral Artery; ICA, Internal Carotid Artery; NIHSS, National Institutes of Health Stroke Scale.
背景:最近关于缺血性卒中血管内治疗的有利队列研究主要使用了 NeVa 血栓切除术(NeVaTM)支架回收器。我们进行了一项系统性回顾和荟萃分析,研究这种第二代支架取出器在急性缺血性卒中患者中的疗效和安全性:我们根据系统综述和荟萃分析首选报告项目(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)指南进行了研究。我们在PubMed、Embase和Scopus等电子数据库中进行了检索,直至2023年11月26日,并于2024年8月1日进行了更新:这项荟萃分析系统地调查了 11 项研究,共涉及 805 名缺血性中风患者。研究参与者的平均年龄在 65 岁至 77 岁之间,男性占 50.16%。虽然有 10 项研究报告了脑卒中的病因,但也有一些研究报告了高血压、血脂异常、糖尿病、冠心病史和既往脑卒中等风险因素。我们的研究结果表明,全出血性并发症发生率为 0.32(95 %CI:0.18-0.45),而动脉完全再通率为 0.76 [95 %CI:0.49-1.04]。总体再通率为 0.97 [95 %CI: 0.94-1.00]。此外,术后出血率为 0.28 [95 %CI:0.14-0.41],而重复再血栓形成率为 0.01 [95 %CI:-0.01-0.03]。最后,血管痉挛率为 0.09 [95 %CI: -0.03-0.21]:NeVa™是一种安全的选择,能够实现较高的再通率和功能独立性:缩写:PRISMA,系统综述和荟萃分析首选报告项目;PROSPERO,国际系统综述前瞻性注册;NeVa™,NeVa血栓切除术;ICH,颅内出血;mTICI,改良的脑梗塞溶栓治疗;mRS,改良的兰金量表;ACA,大脑前动脉;MCA,大脑中动脉;PCA,大脑后动脉;ICA,颈内动脉;NIHSS,美国国立卫生研究院卒中量表。
{"title":"The safety and efficacy of NeVa mechanical thrombectomy device in acute ischemic stroke: A systematic review and meta-analysis","authors":"Mohammad Amin Habibi ,&nbsp;Mohammad Sina Mirjnani ,&nbsp;Saeed Kargar-Soleimanabad ,&nbsp;Mohammad Taha Akbari Javar ,&nbsp;Maryam Diyanati ,&nbsp;Muhammad Hussain Ahmadvand ,&nbsp;Inka K. Berglar ,&nbsp;Adam A. Dmytriw","doi":"10.1016/j.jocn.2024.110892","DOIUrl":"10.1016/j.jocn.2024.110892","url":null,"abstract":"<div><h3>Background</h3><div>Recent favorable cohort studies on endovascular therapy for ischemic stroke have predominantly utilized NeVa thrombectomy (NeVa<sup>TM)</sup> stent retrievers. We carried out a systematic review and <em>meta</em>-analysis to investigate the efficacy and safety of this second-generation stent retriever in acute ischemic stroke patients.</div></div><div><h3>Method</h3><div>We conducted the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The electronic databases of PubMed, Embase, and Scopus were searched until 26 November 2023 and was updated on August 1, 2024.</div></div><div><h3>Results</h3><div>This <em>meta</em>-analysis systematically investigated 11 studies with a total of 805 patients suffering from ischemic stroke. The mean age of participants across the studies ranged from 65 to 77 years with a male preponderance of 50.16 %. While ten studies reported on the etiology of strokes, some studies reported the risk factors such as hypertension, dyslipidemia, diabetes, history of coronary artery disease, and previous stroke. The results of our study indicate that the all-hemorrhagic complications rate was 0.32 (95 %CI: 0.18–0.45), while the complete arterial recanalization rate was 0.76 [95 %CI: 0.49–1.04]. The overall recanalization rate was found to be 0.97 [95 %CI: 0.94–1.00]. Moreover, the postoperative hemorrhage rate was 0.28 [95 %CI: 0.14–0.41], while the repeated re-thrombosis rate was 0.01 [95 %CI: −0.01–0.03]. Lastly, the vasospasm rate was calculated to be 0.09 [95 %CI: −0.03–0.21].</div></div><div><h3>Conclusion</h3><div>NeVa™ is a safe option capable of achieving a high rate of recanalization and functional independence.</div><div>Abbreviations: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO, International Prospective Register of Systematic Reviews; NeVa™, NeVa Thrombectomy; ICH, Intracranial Hemorrhage; mTICI, modified Thrombolysis in Cerebral Infarction; mRS, modified Rankin Scale; ACA, Anterior Cerebral Artery; MCA, Middle Cerebral Artery; PCA, Posterior Cerebral Artery; ICA, Internal Carotid Artery; NIHSS, National Institutes of Health Stroke Scale.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110892"},"PeriodicalIF":1.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does gender diversity affect the number and impact of publications among major academic institutes in India? Barriers and opportunities 性别多样性是否影响印度主要学术机构的出版物数量和影响?障碍与机遇
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-28 DOI: 10.1016/j.jocn.2024.110888
Harsh Deora , Vishnu Jayan , Sandeep Mishra , Shweta Kedia , Vivek Tandon , Kanwaljeet Garg , P.S. Chandra , Shashank Sharad Kale

Background

A glaring gender inequality persists in global neurosurgery, influenced by various factors, including the notion that female neurosurgeons have lower academic output. This study aims to compare the research output of female and male neurosurgeons at the leading academic institutions in India.

Methods

The pertinent details regarding female neurosurgeons were collected from the Neurological Society of India (NSI) and Women In Neurosurgery (India) database. The institutes with at least five neurosurgery faculty recognised by the Medical Council of India (MCI) were included in the study. Various bibliometric parameters of male and female faculty at these academic centres were collected and compared using PubMed and Web of Science databases.

Results

Among the 2643 neurosurgeons in NSI, 113 were females (4.27%). Out of 156 faculty members across eighteen academic institutions, only seven (4.7%) were female, with eleven institutions lacking female faculty. Female academic neurosurgeons had slightly higher h-index (9.57 vs. 9.56), citation per publication (8.82 vs. 8.54), and original article percentage (47.5 vs. 46.5) compared to males. They also had more citations per year (34.01 vs. 33.17), while males had more total publications (51.19 vs. 46.71) and citations (565.22 vs. 533.57), but these differences weren’t statistically significant. Only 4.1% (327/7955) of neurosurgery research was contributed by females. Female neurosurgeons authored articles received 3735 citations (4.2%) out of 87,953 total citations.

Conclusion

Female academic neurosurgeons in India exhibit comparable or superior academic output compared to their male counterparts, suggesting gender equality or even superiority in certain aspects of academic performance.
背景受各种因素的影响,包括女性神经外科医生学术成果较低的观念,全球神经外科领域一直存在着明显的性别不平等现象。本研究旨在比较印度主要学术机构中女性和男性神经外科医生的研究成果。方法从印度神经学会(NSI)和印度女性神经外科数据库中收集了女性神经外科医生的相关详细信息。研究对象包括至少有五名神经外科教师获得印度医学委员会(MCI)认可的机构。研究使用 PubMed 和 Web of Science 数据库收集并比较了这些学术中心男女教师的各种文献计量参数。在 18 个学术机构的 156 名教职员工中,只有 7 名女性(4.7%),11 个机构没有女性教职员工。与男性相比,女性学术神经外科医生的 h 指数(9.57 对 9.56)、每篇论文引用次数(8.82 对 8.54)和原创文章比例(47.5 对 46.5)略高。他们每年的引用次数也更多(34.01 对 33.17),而男性的论文总数(51.19 对 46.71)和引用次数(565.22 对 533.57)更多,但这些差异在统计上并不显著。只有4.1%(327/7955)的神经外科研究是由女性贡献的。在87953次总引用中,女性神经外科医生撰写的文章获得了3735次引用(4.2%)。结论印度的女性神经外科医生与男性神经外科医生相比,在学术成果上不相上下,甚至更胜一筹,这表明在学术表现的某些方面,两性是平等的,甚至更胜一筹。
{"title":"Does gender diversity affect the number and impact of publications among major academic institutes in India? Barriers and opportunities","authors":"Harsh Deora ,&nbsp;Vishnu Jayan ,&nbsp;Sandeep Mishra ,&nbsp;Shweta Kedia ,&nbsp;Vivek Tandon ,&nbsp;Kanwaljeet Garg ,&nbsp;P.S. Chandra ,&nbsp;Shashank Sharad Kale","doi":"10.1016/j.jocn.2024.110888","DOIUrl":"10.1016/j.jocn.2024.110888","url":null,"abstract":"<div><h3>Background</h3><div>A glaring gender inequality persists in global neurosurgery, influenced by various factors, including the notion that female neurosurgeons have lower academic output. This study aims to compare the research output of female and male neurosurgeons at the leading academic institutions in India.</div></div><div><h3>Methods</h3><div>The pertinent details regarding female neurosurgeons were collected from the Neurological Society of India (NSI) and Women In Neurosurgery (India) database. The institutes with at least five neurosurgery faculty recognised by the Medical Council of India (MCI) were included in the study. Various bibliometric parameters of male and female faculty at these academic centres were collected and compared using PubMed and Web of Science databases.</div></div><div><h3>Results</h3><div>Among the 2643 neurosurgeons in NSI, 113 were females (4.27%). Out of 156 faculty members across eighteen academic institutions, only seven (4.7%) were female, with eleven institutions lacking female faculty. Female academic neurosurgeons had slightly higher h-index (9.57 vs. 9.56), citation per publication (8.82 vs. 8.54), and original article percentage (47.5 vs. 46.5) compared to males. They also had more citations per year (34.01 vs. 33.17), while males had more total publications (51.19 vs. 46.71) and citations (565.22 vs. 533.57), but these differences weren’t statistically significant. Only 4.1% (327/7955) of neurosurgery research was contributed by females. Female neurosurgeons authored articles received 3735 citations (4.2%) out of 87,953 total citations.</div></div><div><h3>Conclusion</h3><div>Female academic neurosurgeons in India exhibit comparable or superior academic output compared to their male counterparts, suggesting gender equality or even superiority in certain aspects of academic performance.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110888"},"PeriodicalIF":1.9,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Same-day discharge following lumbar spine neural decompression 腰椎神经减压术后当天出院。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-25 DOI: 10.1016/j.jocn.2024.110875
Halil Bulut , Maria Maestre , Daniel Tomey

Introduction

The concept of same-day discharge following lumbar spine surgery for neural elements decompression, introduced in the 1980 s, represents a significant paradigm shift in postoperative care, offering potential benefits in terms of efficiency, convenience, and cost-effectiveness. However, concerns regarding patient safety and complications have persisted. This study aims to assess same-day discharge rates following lumbar spine decompression surgery, identify preoperative predictors, and compare outcomes between same-day discharge and hospitalization.

Methods

A retrospective comparative analysis was conducted using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Participant Use File spanning 2016 to 2021. A total of 58,430 patients undergoing lumbar spine decompression procedures were included. Statistical analysis was performed using SPSS software, with significance determined at p < 0.05.

Results

Significant differences were observed in preoperative factors, operative variables, and postoperative outcomes between patients discharged on the same day and those hospitalized. Preoperative comorbidities, operative time, length of stay, utilization of minimally invasive approaches, and 30-day mortality rates differed significantly between the two groups. Notably, same-day discharge demonstrated superior outcomes, with lower rates of unplanned intubation, readmission, and reoperation compared to hospitalization.

Conclusion

In conclusion, same-day discharge following lumbar spine decompression procedures holds promise as a safe and effective practice, offering advantages in terms of patient outcomes and healthcare resource utilization. Further research and implementation of standardized protocols are warranted to maximize the benefits of same-day discharge while ensuring patient safety and satisfaction.
导言:腰椎神经元减压手术后当天出院的概念于 20 世纪 80 年代提出,代表着术后护理模式的重大转变,在效率、便利性和成本效益方面都具有潜在的优势。然而,有关患者安全和并发症的担忧一直存在。本研究旨在评估腰椎减压术后当日出院率,确定术前预测因素,并比较当日出院和住院治疗的结果:方法:利用美国外科学院国家外科质量改进计划(ACS NSQIP)参与者使用文件中2016年至2021年的数据进行了回顾性比较分析。共纳入了58430名接受腰椎减压术的患者。使用 SPSS 软件进行统计分析,以 p 为显著性判定结果:当天出院的患者与住院的患者在术前因素、手术变量和术后结果方面存在显著差异。两组患者的术前合并症、手术时间、住院时间、微创方法的使用以及 30 天死亡率均有显著差异。值得注意的是,与住院治疗相比,当天出院的疗效更佳,意外插管率、再入院率和再次手术率更低:总之,腰椎减压术后当天出院是一种安全有效的做法,在患者预后和医疗资源利用方面具有优势。为了最大限度地发挥当天出院的优势,同时确保患者的安全和满意度,有必要开展进一步的研究并实施标准化方案。
{"title":"Same-day discharge following lumbar spine neural decompression","authors":"Halil Bulut ,&nbsp;Maria Maestre ,&nbsp;Daniel Tomey","doi":"10.1016/j.jocn.2024.110875","DOIUrl":"10.1016/j.jocn.2024.110875","url":null,"abstract":"<div><h3>Introduction</h3><div>The concept of same-day discharge following lumbar spine surgery for neural elements decompression, introduced in the 1980 s, represents a significant paradigm shift in postoperative care, offering potential benefits in terms of efficiency, convenience, and cost-effectiveness. However, concerns regarding patient safety and complications have persisted. This study aims to assess same-day discharge rates following lumbar spine decompression surgery, identify preoperative predictors, and compare outcomes between same-day discharge and hospitalization.</div></div><div><h3>Methods</h3><div>A retrospective comparative analysis was conducted using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Participant Use File spanning 2016 to 2021. A total of 58,430 patients undergoing lumbar spine decompression procedures were included. Statistical analysis was performed using SPSS software, with significance determined at p &lt; 0.05.</div></div><div><h3>Results</h3><div>Significant differences were observed in preoperative factors, operative variables, and postoperative outcomes between patients discharged on the same day and those hospitalized. Preoperative comorbidities, operative time, length of stay, utilization of minimally invasive approaches, and 30-day mortality rates differed significantly between the two groups. Notably, same-day discharge demonstrated superior outcomes, with lower rates of unplanned intubation, readmission, and reoperation compared to hospitalization.</div></div><div><h3>Conclusion</h3><div>In conclusion, same-day discharge following lumbar spine decompression procedures holds promise as a safe and effective practice, offering advantages in terms of patient outcomes and healthcare resource utilization. Further research and implementation of standardized protocols are warranted to maximize the benefits of same-day discharge while ensuring patient safety and satisfaction.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110875"},"PeriodicalIF":1.9,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic endonasal transpterygoid trans lacero-cavernous resection of Knosp 4 functioning pituitary macroadenoma 内窥镜下经蝶窦经腔镜切除 Knosp 4 功能性垂体大腺瘤。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-24 DOI: 10.1016/j.jocn.2024.110886
Jaskaran Singh Gosal , Pavan Gabra , Simran Bhalla , Raghavendra Kumar Sharma , Vikas Janu , Sarbesh Tiwari , Nikhil Agrawal , Ravindra Kumar Shukla , Mahesh Gadhvi , Daniel Prevedello , Deepak Kumar Jha
In this video, we demonstrate the technique of endoscopic transpterygoid trans lacerum trans cavernous approach for the excision of Knosp 4 functioning pituitary macroadenomas. We highlight the anatomy and key steps of the approach using cadaveric dissection and present two clinical cases. A 42-year-old female with a growth hormone-secreting tumor and Knosp 4 macroadenoma underwent an extended endoscopic endonasal approach and near-total excision of the tumor. Postoperatively she was neurologically intact. Postoperative MR showed a small residue in the lateral compartment of the cavernous sinus and along the right optic tract superiorly. Due to the proximity of the residual tumor near the optic apparatus, she was offered a pterional approach, and the tumor around the optic apparatus was excised. She was given stereotactic radiosurgery for the small residual tumor in the cavernous sinus and is currently doing well, under remission. The second case was a 23-year young male with acromegaly and bilateral Knosp 4 macroadenoma. He underwent endoscopic transpterygoid trans lacerum trans cavernous approach and gross total excision of the tumor was done. He had transient bilateral ophthalmoplegia in the immediate postoperative period which recovered fully within 6 weeks. He is currently in remission without any need for radiotherapy. To conclude, an in-depth knowledge of the anatomy helps in improving surgical outcomes in extended endoscopic endonasal surgeries.
在这段视频中,我们展示了内镜下经蝶孔经裂隙经海绵方法切除 Knosp 4 功能性垂体大腺瘤的技术。我们利用尸体解剖强调了该方法的解剖结构和关键步骤,并介绍了两个临床病例。一名 42 岁女性患有分泌生长激素的肿瘤和 Knosp 4 大腺瘤,她接受了扩展内窥镜鼻内入路手术,几乎完全切除了肿瘤。术后她的神经系统完好无损。术后磁共振成像显示,海绵窦外侧和右侧视束上沿有少量残留物。由于残留肿瘤靠近视神经器,她接受了翼状切口,并切除了视神经器周围的肿瘤。她接受了立体定向放射外科手术治疗海绵窦内的小残余肿瘤,目前情况良好,正在缓解中。第二个病例是一名 23 岁的年轻男性,患有肢端肥大症和双侧 Knosp 4 巨腺瘤。他接受了内镜下经蝶窦经腔隙经海绵窦入路手术,并对肿瘤进行了全切。术后即刻出现一过性双侧眼球震颤,6周内完全恢复。他目前病情缓解,无需接受放疗。总之,深入了解解剖结构有助于提高扩展内窥镜鼻内手术的手术效果。
{"title":"Endoscopic endonasal transpterygoid trans lacero-cavernous resection of Knosp 4 functioning pituitary macroadenoma","authors":"Jaskaran Singh Gosal ,&nbsp;Pavan Gabra ,&nbsp;Simran Bhalla ,&nbsp;Raghavendra Kumar Sharma ,&nbsp;Vikas Janu ,&nbsp;Sarbesh Tiwari ,&nbsp;Nikhil Agrawal ,&nbsp;Ravindra Kumar Shukla ,&nbsp;Mahesh Gadhvi ,&nbsp;Daniel Prevedello ,&nbsp;Deepak Kumar Jha","doi":"10.1016/j.jocn.2024.110886","DOIUrl":"10.1016/j.jocn.2024.110886","url":null,"abstract":"<div><div>In this video, we demonstrate the technique of endoscopic transpterygoid trans lacerum trans cavernous approach for the excision of Knosp 4 functioning pituitary macroadenomas. We highlight the anatomy and key steps of the approach using cadaveric dissection and present two clinical cases. A 42-year-old female with a growth hormone-secreting tumor and Knosp 4 macroadenoma underwent an extended endoscopic endonasal approach and near-total excision of the tumor. Postoperatively she was neurologically intact. Postoperative MR showed a small residue in the lateral compartment of the cavernous sinus and along the right optic tract superiorly. Due to the proximity of the residual tumor near the optic apparatus, she was offered a pterional approach, and the tumor around the optic apparatus was excised. She was given stereotactic radiosurgery for the small residual tumor in the cavernous sinus and is currently doing well, under remission. The second case was a 23-year young male with acromegaly and bilateral Knosp 4 macroadenoma. He underwent endoscopic transpterygoid trans lacerum trans cavernous approach and gross total excision of the tumor was done. He had transient bilateral ophthalmoplegia in the immediate postoperative period which recovered fully within 6 weeks. He is currently in remission without any need for radiotherapy. To conclude, an in-depth knowledge of the anatomy helps in improving surgical outcomes in extended endoscopic endonasal surgeries.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"129 ","pages":"Article 110886"},"PeriodicalIF":1.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uninostril endonasal trans-sphenoidal approach for pituitary macroadenoma–Operative nuances step by step 垂体大腺瘤的单鼻内镜经蝶窦入路手术--手术中的微妙步骤。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-24 DOI: 10.1016/j.jocn.2024.110867
A. Mittal, R. Mishra, I. Jain, H. Patel, A. Shrivastava
The Uninostril Endonasal Transsphenoidal approach stands out for its ability to preserve nasal anatomy, ensuring normal postoperative breathing while reducing postoperative nasal complications. The Uninostril approach offers a simplified access, expedites both the nasal phase and closure, all while leaving the contralateral nostril untouched, allowing for a potential rescue flap if needed. This method is particularly suited for primary cases of sellar suprasellar Knosp 0/1 pituitary adenomas located medial to the carotid arteries and with T2 iso to hyperintense signals on the MRI. The objective of this article is to elucidate the operative step by step nuances of the uninostril endonasal trans-sphenoidal surgery.
The patient positioning is key with a neutral head alignment positioned above the heart level and slightly tilted to the opposite side. This position is ergonomically better, reduces the venous bleeding, and enhances gravity-assisted tumor removal. Despite its advantages—such as improved postoperative nasal quality and a comparable rate of gross total tumor resection to the Bi-nostril approach—the Uninostril technique is not without limitations. Challenges include a restricted field of view, limited instrument maneuverability, and the potential need to convert to a Bi-nostril approach in cases of excessive bleeding or visualization difficulties. Overall, this approach provides a viable alternative for pituitary adenoma resection in selected subset of the patients, effectively balancing the oncologic resection and patient’s related outcomes.
Uninostril 鼻孔内经鼻腔方法的突出特点是能够保留鼻腔解剖结构,确保术后正常呼吸,同时减少术后鼻腔并发症。单鼻孔方法提供了简化的入路,加快了鼻腔阶段和闭合的速度,同时不触及对侧鼻孔,以便在需要时进行潜在的抢救性皮瓣。这种方法尤其适用于位于颈动脉内侧、核磁共振成像呈 T2 等强到高强信号的蝶鞍上 Knosp 0/1 垂体腺瘤的原发性病例。本文旨在阐明经蝶窦无鼻孔内手术的操作步骤的细微差别。患者的体位是关键,头部保持中立,位置高于心脏水平,并稍微向对侧倾斜。这种体位更符合人体工程学,可减少静脉出血,并加强重力辅助肿瘤切除。尽管 Uninostril 技术具有改善术后鼻腔质量和与双鼻孔方法相当的肿瘤总切除率等优点,但它也并非没有局限性。面临的挑战包括视野受限、器械可操作性有限,以及在出血过多或观察困难的情况下可能需要转换为双鼻孔方法。总之,这种方法为部分患者的垂体腺瘤切除术提供了一种可行的选择,有效地平衡了肿瘤切除和患者的相关结果。
{"title":"Uninostril endonasal trans-sphenoidal approach for pituitary macroadenoma–Operative nuances step by step","authors":"A. Mittal,&nbsp;R. Mishra,&nbsp;I. Jain,&nbsp;H. Patel,&nbsp;A. Shrivastava","doi":"10.1016/j.jocn.2024.110867","DOIUrl":"10.1016/j.jocn.2024.110867","url":null,"abstract":"<div><div>The Uninostril Endonasal Transsphenoidal approach stands out for its ability to preserve nasal anatomy, ensuring normal postoperative breathing while reducing postoperative nasal complications. The Uninostril approach offers a simplified access, expedites both the nasal phase and closure, all while leaving the contralateral nostril untouched, allowing for a potential rescue flap if needed. This method is particularly suited for primary cases of sellar suprasellar Knosp 0/1 pituitary adenomas located medial to the carotid arteries and with T2 iso to hyperintense signals on the MRI. The objective of this article is to elucidate the operative step by step nuances of the uninostril endonasal <em>trans</em>-sphenoidal surgery.</div><div>The patient positioning is key with a neutral head alignment positioned above the heart level and slightly tilted to the opposite side. This position is ergonomically better, reduces the venous bleeding, and enhances gravity-assisted tumor removal. Despite its advantages—such as improved postoperative nasal quality and a comparable rate of gross total tumor resection to the Bi-nostril approach—the Uninostril technique is not without limitations. Challenges include a restricted field of view, limited instrument maneuverability, and the potential need to convert to a Bi-nostril approach in cases of excessive bleeding or visualization difficulties. Overall, this approach provides a viable alternative for pituitary adenoma resection in selected subset of the patients, effectively balancing the oncologic resection and patient’s related outcomes.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110867"},"PeriodicalIF":1.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volume-staged versus dose-staged stereotactic radiosurgery, with or without embolization, in the treatment of large brain arteriovenous malformations: A systematic review and meta-analysis 在治疗大面积脑动静脉畸形时,体积分期与剂量分期立体定向放射外科手术(有无栓塞)的比较:系统回顾和荟萃分析。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-24 DOI: 10.1016/j.jocn.2024.110883
Collin J. Larkin , Zachary A. Abecassis , Ketan Yerneni , Dominic A. Nistal , Constantine L. Karras , Pedram Golnari , Matthew B. Potts , Babak S. Jahromi

Background and objective

While safe and effective modalities exist to treat small arteriovenous malformations (AVMs), large (>10 cm3) AVMs remain difficult to cure via surgical or endovascular means. Staged stereotactic radiosurgery (SRS), either volume-staged (VS) or dose-staged (DS), has been proposed for large AVMs. The relative efficacy of these two strategies, with or without endovascular embolization, is unclear. Accordingly, the goal of this study is to review existing literature on VS-SRS and DS-SRS for large brain AVMs to compare obliteration rates and complications, and determine the utility of neoadjuvant embolization.

Methods

MEDLINE, Scopus, and the Cochrane registry were searched for studies with at least five adult patients and an AVM volume of ≥10 cm3 prior to treatment. Meta-analyses of proportions were conducted and compared using a Wald-type test and the impact of prior embolization was investigated using weighted linear regression analysis.

Results

Eighteen studies (VS-SRS n = 235, DS-SRS n = 157) fit inclusion criteria, all of which were retrospective and none of which directly compared both treatment strategies. The average rate of complete AVM obliteration was significantly higher with VS-SRS (46.6 %; 39.7 % – 53.6 %) than DS-SRS (17.8 %; 7.0 % – 38.2 %, p = 0.027). Complication rates were comparable between VS-SRS (18.0 %; 9.2 % – 32.1 %) and DS-SRS (23.6 %; 12.2 % – 40.8 %, p = 0.544). Regression analysis demonstrated no significant relationship between prior embolization and complete obliteration for either VS-SRS (r = −0.36, p = 0.34) or DS-SRS (r = 0.58, p = 0.29).

Conclusion

VS-SRS, without neoadjuvant embolization, appears to be the optimal approach when treating large AVMs with radiosurgery. Further prospective studies are warranted.
背景和目的:虽然已有安全有效的方法治疗小的动静脉畸形(AVM),但大的动静脉畸形(>10 立方厘米)仍然难以通过手术或血管内方法治愈。对于大的动静脉畸形,有人提出了分期立体定向放射手术(SRS),即体积分期(VS)或剂量分期(DS)。目前还不清楚这两种策略在进行或不进行血管内栓塞时的相对疗效。因此,本研究旨在回顾有关 VS-SRS 和 DS-SRS 治疗大面积脑动静脉畸形的现有文献,以比较阻塞率和并发症,并确定新辅助栓塞的效用:方法: 在 MEDLINE、Scopus 和 Cochrane 注册中心检索了至少有五名成年患者且治疗前 AVM 体积≥10 立方厘米的研究。使用 Wald 型检验对比例进行了元分析和比较,并使用加权线性回归分析研究了先前栓塞的影响:18项研究(VS-SRS n = 235,DS-SRS n = 157)符合纳入标准,所有研究均为回顾性研究,没有一项研究直接比较两种治疗策略。VS-SRS 的 AVM 完全阻塞率(46.6%;39.7% - 53.6%)明显高于 DS-SRS(17.8%;7.0% - 38.2%,P = 0.027)。VS-SRS (18.0 %; 9.2 % - 32.1 %) 和 DS-SRS (23.6 %; 12.2 % - 40.8 %, p = 0.544) 的并发症发生率相当。回归分析表明,无论是VS-SRS(r = -0.36,p = 0.34)还是DS-SRS(r = 0.58,p = 0.29),事先栓塞与完全阻塞之间均无明显关系:结论:在使用放射外科手术治疗大面积 AVM 时,不进行新辅助栓塞的 VS-SRS 似乎是最佳方法。结论:在使用放射外科手术治疗大面积 AVM 时,不进行新辅助栓塞的 VS-SRS 似乎是最佳方法。
{"title":"Volume-staged versus dose-staged stereotactic radiosurgery, with or without embolization, in the treatment of large brain arteriovenous malformations: A systematic review and meta-analysis","authors":"Collin J. Larkin ,&nbsp;Zachary A. Abecassis ,&nbsp;Ketan Yerneni ,&nbsp;Dominic A. Nistal ,&nbsp;Constantine L. Karras ,&nbsp;Pedram Golnari ,&nbsp;Matthew B. Potts ,&nbsp;Babak S. Jahromi","doi":"10.1016/j.jocn.2024.110883","DOIUrl":"10.1016/j.jocn.2024.110883","url":null,"abstract":"<div><h3>Background and objective</h3><div>While safe and effective modalities exist to treat small arteriovenous malformations (AVMs), large (&gt;10 cm<sup>3</sup>) AVMs remain difficult to cure via surgical or endovascular means. Staged stereotactic radiosurgery (SRS), either volume-staged (VS) or dose-staged (DS), has been proposed for large AVMs. The relative efficacy of these two strategies, with or without endovascular embolization, is unclear. Accordingly, the goal of this study is to review existing literature on VS-SRS and DS-SRS for large brain AVMs to compare obliteration rates and complications, and determine the utility of neoadjuvant embolization.</div></div><div><h3>Methods</h3><div>MEDLINE, Scopus, and the Cochrane registry were searched for studies with at least five adult patients and an AVM volume of ≥10 cm<sup>3</sup> prior to treatment. Meta-analyses of proportions were conducted and compared using a Wald-type test and the impact of prior embolization was investigated using weighted linear regression analysis.</div></div><div><h3>Results</h3><div>Eighteen studies (VS-SRS n = 235, DS-SRS n = 157) fit inclusion criteria, all of which were retrospective and none of which directly compared both treatment strategies. The average rate of complete AVM obliteration was significantly higher with VS-SRS (46.6 %; 39.7 % – 53.6 %) than DS-SRS (17.8 %; 7.0 % – 38.2 %, p = 0.027). Complication rates were comparable between VS-SRS (18.0 %; 9.2 % – 32.1 %) and DS-SRS (23.6 %; 12.2 % – 40.8 %, p = 0.544). Regression analysis demonstrated no significant relationship between prior embolization and complete obliteration for either VS-SRS (r = −0.36, <em>p</em> = 0.34) or DS-SRS (r = 0.58, <em>p</em> = 0.29).</div></div><div><h3>Conclusion</h3><div>VS-SRS, without neoadjuvant embolization, appears to be the optimal approach when treating large AVMs with radiosurgery. Further prospective studies are warranted.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"129 ","pages":"Article 110883"},"PeriodicalIF":1.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of time to achieve clinically significant improvements following lateral lumbar interbody fusion 腰椎侧位椎体间融合术后临床症状明显改善所需时间的预测因素。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-24 DOI: 10.1016/j.jocn.2024.110889
Fatima N. Anwar , Andrea M. Roca , Vishrudh Vasudevan , Yousaf Ilyas , Alexandra C. Loya , Srinath S. Medakkar , Vincent P. Federico , Kern Singh

Background

As lateral lumbar interbody fusions (LLIF) are increasingly performed, our understanding of postoperative clinical trajectories is important in informing preoperative patient expectations. While minimum clinically important difference (MCID) rates are widely utilized in spine surgery literature, there is less published on how long it takes for patients to achieve MCID following LLIF.

Objective

To evaluate the length of time it takes for patients to report MCID achievement for back pain, leg pain, disability, and physical function and evaluate predictors of time to achieve MCID.

Methods

Patients undergoing elective LLIF by the senior author with baseline and postoperative patient-reported outcomes (PROs) recorded were retrospectively identified. Data on potential predictors of time to MCID achievement were gathered including demographics, comorbidities, diagnostic information, and baseline PROs. MCID achievement rates for Oswestry Disability Index (ODI), Visual Analog Scale-Back (VAS-Back), VAS-Leg, and Patient-Reported Outcome Measurement Information System-Physical Function (PROMIS-PF) were calculated at six-, twelve, 6 month- 1 year- and 2-year postoperative timepoints. A Kaplan-Meier survival analysis was conducted to determine the proportion of patients achieving MCID at each time point. A multivariate Cox regression determined predictors of time to MCID achievement.

Results

One hundred-five patients were included in the analysis. The mean time to achieve MCID for PROMIS-PF was 44.7 weeks, for VAS-Back was 38.5 weeks, for VAS-Leg was 36.7 weeks, and for ODI was 38.3 weeks. Worse baseline VAS-Back significantly predicted earlier MCID achievement for VAS-Back (HR: 1.55), while diabetes was predictive of later MCID achievement (HR: 0.21). Higher body mass index and worse preoperative ODI predicted earlier MCID achievement for ODI (HR: 1.04–1.08), and higher VAS-Leg score and two-level fusion were predictive of later MCID achievement for ODI, (HR:0.26–0.81). Worse preoperative VAS-Leg, isthmic spondylolisthesis, and three-level fusion were predictors of earlier achievement of MCID for VAS-Leg (HR: 1.27–6.47). Herniated nucleus pulposus and foraminal stenosis were early predictors (HR: 2.92–3.23) and workers’ compensation was a late predictor of MCID attainment for PROMIS-PF (HR: 0.13).

Conclusion

Select demographic variables, comorbidities, spinal pathology, and preoperative PROs influenced the time it took for patients to report clinically significant improvements in pain, disability, and physical function scores. These findings can be used to prognosticate outcomes for patients undergoing LLIF and inform patient expectations of postoperative recovery.
背景:随着腰椎侧位椎体间融合术(LLIF)的实施越来越多,我们对术后临床轨迹的了解对于告知患者术前期望非常重要。虽然脊柱手术文献中广泛使用最小临床重要差异(MCID)率,但关于患者在 LLIF 术后多久才能达到 MCID 的文献却较少:目的:评估患者报告腰痛、腿痛、残疾和身体功能达到 MCID 所需的时间长度,并评估达到 MCID 所需的时间预测因素:方法:对资深作者进行的选择性 LLIF 患者进行回顾性鉴定,记录患者报告的基线和术后结果 (PRO)。收集了MCID达标时间潜在预测因素的数据,包括人口统计学、合并症、诊断信息和基线PROs。计算了术后 6 个月、12 个月、6 个月-1 年和 2 年时间点的 Oswestry 失能指数 (ODI)、视觉模拟量表-背 (VAS-背)、视觉模拟量表-腿 (VAS-Leg) 和患者报告结果测量信息系统-身体功能 (PROMIS-PF) 的 MCID 达标率。卡普兰-梅耶生存分析确定了在每个时间点达到 MCID 的患者比例。多变量考克斯回归确定了达到 MCID 时间的预测因素:分析共纳入了 15 名患者。PROMIS-PF达到MCID的平均时间为44.7周,VAS-Back为38.5周,VAS-Leg为36.7周,ODI为38.3周。基线VAS-Back较差可显著预测VAS-Back较早达到MCID(HR:1.55),而糖尿病可预测较晚达到MCID(HR:0.21)。较高的体重指数和较差的术前 ODI 预测较早达到 ODI 的 MCID 指标(HR:1.04-1.08),较高的 VAS-Leg 评分和两级融合预测较晚达到 ODI 的 MCID 指标(HR:0.26-0.81)。术前较差的 VAS-Leg、峡部脊柱滑脱和三水平融合是较早达到 VAS-Leg MCID 的预测因素(HR:1.27-6.47)。髓核突出和椎间孔狭窄是早期预测因素(HR:2.92-3.23),而工伤是PROMIS-PF达到MCID的晚期预测因素(HR:0.13):结论:选定的人口统计学变量、合并症、脊柱病理和术前PROs会影响患者报告疼痛、残疾和身体功能评分临床显著改善所需的时间。这些发现可用于预测接受 LLIF 治疗的患者的预后,并告知患者对术后恢复的期望。
{"title":"Predictors of time to achieve clinically significant improvements following lateral lumbar interbody fusion","authors":"Fatima N. Anwar ,&nbsp;Andrea M. Roca ,&nbsp;Vishrudh Vasudevan ,&nbsp;Yousaf Ilyas ,&nbsp;Alexandra C. Loya ,&nbsp;Srinath S. Medakkar ,&nbsp;Vincent P. Federico ,&nbsp;Kern Singh","doi":"10.1016/j.jocn.2024.110889","DOIUrl":"10.1016/j.jocn.2024.110889","url":null,"abstract":"<div><h3>Background</h3><div>As lateral lumbar interbody fusions (LLIF) are increasingly performed, our understanding of postoperative clinical trajectories is important in informing preoperative patient expectations. While minimum clinically important difference (MCID) rates are widely utilized in spine surgery literature, there is less published on how long it takes for patients to achieve MCID following LLIF.</div></div><div><h3>Objective</h3><div>To evaluate the length of time it takes for patients to report MCID achievement for back pain, leg pain, disability, and physical function and evaluate predictors of time to achieve MCID.</div></div><div><h3>Methods</h3><div>Patients undergoing elective LLIF by the senior author with baseline and postoperative patient-reported outcomes (PROs) recorded were retrospectively identified. Data on potential predictors of time to MCID achievement were gathered including demographics, comorbidities, diagnostic information, and baseline PROs. MCID achievement rates for Oswestry Disability Index (ODI), Visual Analog Scale-Back (VAS-Back), VAS-Leg, and Patient-Reported Outcome Measurement Information System-Physical Function (PROMIS-PF) were calculated at six-, twelve, 6 month- 1 year- and 2-year postoperative timepoints. A Kaplan-Meier survival analysis was conducted to determine the proportion of patients achieving MCID at each time point. A multivariate Cox regression determined predictors of time to MCID achievement.</div></div><div><h3>Results</h3><div>One hundred-five patients were included in the analysis. The mean time to achieve MCID for PROMIS-PF was 44.7 weeks, for VAS-Back was 38.5 weeks, for VAS-Leg was 36.7 weeks, and for ODI was 38.3 weeks. Worse baseline VAS-Back significantly predicted earlier MCID achievement for VAS-Back (HR: 1.55), while diabetes was predictive of later MCID achievement (HR: 0.21). Higher body mass index and worse preoperative ODI predicted earlier MCID achievement for ODI (HR: 1.04–1.08), and higher VAS-Leg score and two-level fusion were predictive of later MCID achievement for ODI, (HR:0.26–0.81). Worse preoperative VAS-Leg, isthmic spondylolisthesis, and three-level fusion were predictors of earlier achievement of MCID for VAS-Leg (HR: 1.27–6.47). Herniated nucleus pulposus and foraminal stenosis were early predictors (HR: 2.92–3.23) and workers’ compensation was a late predictor of MCID attainment for PROMIS-PF (HR: 0.13).</div></div><div><h3>Conclusion</h3><div>Select demographic variables, comorbidities, spinal pathology, and preoperative PROs influenced the time it took for patients to report clinically significant improvements in pain, disability, and physical function scores. These findings can be used to prognosticate outcomes for patients undergoing LLIF and inform patient expectations of postoperative recovery.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110889"},"PeriodicalIF":1.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of traumatic brain injury treatment guided by continuous monitoring of intracranial pressure and brain tissue oxygen partial pressure: A single-center pilot study 通过持续监测颅内压和脑组织氧分压评估脑外伤治疗:单中心试点研究。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-23 DOI: 10.1016/j.jocn.2024.110884
Zhong Wang , Ruijian Zhang, Zhitong Han, Junqing Wang, Rile Wu, Weiping Zhao, Xiaojun Zhang, Jingang Bao, Weiran Yang, Zhilong Zhang
Severe traumatic brain injury (TBI) is a leading cause of death and disability. Monitoring intracranial pressure (ICP) is recommended, but the data on the outcomes are conflicting. Adding continuous brain tissue oxygen partial pressure (PbtO2) monitoring may have some benefit but the OXY-TC suggested it did not improve 6-month neurological outcomes. This single-center pilot randomized controlled study aimed to evaluate whether adding PbtO2 monitoring was feasible and could improve the prognosis of severe TBI. The participants were randomized into either an ICP alone or an ICP + PbtO2 group for 7 days, with treatment protocols based on existing guidelines. Clinical parameters were collected hourly. The primary outcome was the feasibility of using PbtO2 monitoring. The secondary outcomes were 6-month survival, analyzed by the log-rank test, the 3- and 6-month Glasgow Outcome Scale (GOS) scores, compared between groups by chi-squared test. Seventy patients were included (36 ICP, 34 ICP + PbtO2). The ICP + PbtO2 group had lower mean daily ICP (13.4 vs. 18.2 mmHg, P = 0.0024) and higher mean daily cerebral perfusion pressure (82.1 vs. 74.5 mmHg, P = 0.0055). The ICP + PbtO2 group had higher 6-month survival (79.4 % vs. 55.6 %, P = 0.0337) and more favorable outcomes at 3 months (67.6 % vs. 38.9 %, P = 0.0160) and 6 months (70.6 % vs. 41.7 %, P = 0.0149). Adding PbtO2 monitoring to ICP monitoring is feasible in patients with severe TBI and could maybe improve the intermediate-term outcomes. The results will serve to design larger trials.
严重创伤性脑损伤(TBI)是导致死亡和残疾的主要原因。建议对颅内压(ICP)进行监测,但有关结果的数据却相互矛盾。增加连续脑组织氧分压(PbtO2)监测可能会带来一些益处,但 OXY-TC 研究表明这并不能改善 6 个月的神经功能预后。这项单中心试验性随机对照研究旨在评估增加 PbtO2 监测是否可行,以及能否改善严重创伤性脑损伤的预后。参与者被随机分为单纯 ICP 组或 ICP + PbtO2 组,为期 7 天,治疗方案基于现有指南。每小时收集一次临床参数。主要结果是使用 PbtO2 监测的可行性。次要结果是6个月的存活率(通过对数秩检验进行分析)、3个月和6个月的格拉斯哥结果量表(GOS)评分(通过卡方检验进行组间比较)。共纳入 70 例患者(36 例 ICP,34 例 ICP + PbtO2)。ICP + PbtO2组的日平均ICP较低(13.4 vs. 18.2 mmHg,P = 0.0024),日平均脑灌注压较高(82.1 vs. 74.5 mmHg,P = 0.0055)。ICP + PbtO2 组的 6 个月存活率更高(79.4% 对 55.6%,P = 0.0337),3 个月和 6 个月的预后更佳(67.6% 对 38.9%,P = 0.0160)(70.6% 对 41.7%,P = 0.0149)。在对严重创伤性脑损伤患者进行ICP监测的基础上增加PbtO2监测是可行的,并有可能改善中期预后。这些结果将有助于设计更大规模的试验。
{"title":"Assessment of traumatic brain injury treatment guided by continuous monitoring of intracranial pressure and brain tissue oxygen partial pressure: A single-center pilot study","authors":"Zhong Wang ,&nbsp;Ruijian Zhang,&nbsp;Zhitong Han,&nbsp;Junqing Wang,&nbsp;Rile Wu,&nbsp;Weiping Zhao,&nbsp;Xiaojun Zhang,&nbsp;Jingang Bao,&nbsp;Weiran Yang,&nbsp;Zhilong Zhang","doi":"10.1016/j.jocn.2024.110884","DOIUrl":"10.1016/j.jocn.2024.110884","url":null,"abstract":"<div><div>Severe traumatic brain injury (TBI) is a leading cause of death and disability. Monitoring intracranial pressure (ICP) is recommended, but the data on the outcomes are conflicting. Adding continuous brain tissue oxygen partial pressure (PbtO2) monitoring may have some benefit but the OXY-TC suggested it did not improve 6-month neurological outcomes. This single-center pilot randomized controlled study aimed to evaluate whether adding PbtO2 monitoring was feasible and could improve the prognosis of severe TBI. The participants were randomized into either an ICP alone or an ICP + PbtO2 group for 7 days, with treatment protocols based on existing guidelines. Clinical parameters were collected hourly. The primary outcome was the feasibility of using PbtO2 monitoring. The secondary outcomes were 6-month survival, analyzed by the log-rank test, the 3- and 6-month Glasgow Outcome Scale (GOS) scores, compared between groups by chi-squared test. Seventy patients were included (36 ICP, 34 ICP + PbtO2). The ICP + PbtO2 group had lower mean daily ICP (13.4 vs. 18.2 mmHg, P = 0.0024) and higher mean daily cerebral perfusion pressure (82.1 vs. 74.5 mmHg, P = 0.0055). The ICP + PbtO2 group had higher 6-month survival (79.4 % vs. 55.6 %, P = 0.0337) and more favorable outcomes at 3 months (67.6 % vs. 38.9 %, P = 0.0160) and 6 months (70.6 % vs. 41.7 %, P = 0.0149). Adding PbtO2 monitoring to ICP monitoring is feasible in patients with severe TBI and could maybe improve the intermediate-term outcomes. The results will serve to design larger trials.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"130 ","pages":"Article 110884"},"PeriodicalIF":1.9,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Neuroscience
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1